We are live on ! Find out more
CABA icon

Cabaletta Bio
CABA

52 hedge funds and large institutions have $183M invested in Cabaletta Bio in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 6

275% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 4

56% more capital invested

Capital invested by funds: $117M → $183M (+$65.8M)

27% more funds holding

Funds holding: 41 → 52 (+11)

26.34% more ownership

Funds ownership: 66.92% → 93.27% (+26%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
52
Holders Change
+11
Holders Change %
+26.83%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
24
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.41M
2
Millennium Management
Millennium Management
New York
+$1.83M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.07M
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$775K
5
AGA
Altrinsic Global Advisors
Connecticut
+$766K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$6.28M
2
Victory Capital Management
Victory Capital Management
Texas
-$559K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$361K
4
Norges Bank
Norges Bank
Norway
-$344K
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$304K
Name Holding Trade Value Shares
Change 		Change in
Stake
5VM
1
5AM Venture Management
California
$40.9M – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$39.7M -$304K -39,751 -1%
CAM
3
Cormorant Asset Management
Massachusetts
$23.5M -$15 -2 -0%
BC
4
Boxer Capital
California
$17.4M – – –
RG
5
Redmile Group
California
$15.9M – – –
BBA
6
Baker Bros. Advisors
New York
$7.09M – – –
Millennium Management
7
Millennium Management
New York
$7.04M +$1.83M +239,089 +61%
BlackRock
8
BlackRock
New York
$6.94M +$2.41M +314,401 +102%
DM
9
Deerfield Management
New York
$5.17M -$6.28M -820,061 -64%
Vanguard Group
10
Vanguard Group
Pennsylvania
$2.87M -$361K -47,116 -15%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$2.06M +$279K +36,492 +25%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$1.9M +$1.07M +140,000 +458%
State Street
13
State Street
Massachusetts
$1.49M +$215K +28,093 +27%
Northern Trust
14
Northern Trust
Illinois
$1.46M +$254K +33,191 +34%
Russell Investments Group
15
Russell Investments Group
United Kingdom
$1.13M +$775K +101,165 New
AGA
16
Altrinsic Global Advisors
Connecticut
$1.11M +$766K +100,000 New
Wells Fargo
17
Wells Fargo
California
$941K +$585K +76,361 +942%
Victory Capital Management
18
Victory Capital Management
Texas
$797K -$559K -72,979 -51%
Renaissance Technologies
19
Renaissance Technologies
New York
$685K +$371K +48,447 +373%
Squarepoint
20
Squarepoint
New York
$608K +$322K +42,016 +335%
N
21
Nuveen
North Carolina
$506K +$221K +28,869 +174%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$489K +$174K +22,765 +108%
Morgan Stanley
23
Morgan Stanley
New York
$412K +$240K +31,386 +560%
Charles Schwab
24
Charles Schwab
California
$363K +$106K +13,905 +75%
Goldman Sachs
25
Goldman Sachs
New York
$319K +$25.2K +3,297 +13%
1
2 3

CABA Hedge Fund Activity: Q2 2020 in Review

52 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q2 2020, worth a combined $183M — up 56% from $117M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CABA positions and 4 closed out — a net gain of 11 holders — while 24 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $2.41M. The largest seller was Deerfield Management, cutting an estimated $6.28M.

  • 52 institutional investors held Cabaletta Bio (CABA) as of Q2 2020, up from 41 in Q1 2020.
  • Funds reported $183M of Cabaletta Bio stock for Q2 2020, up 56% quarter-over-quarter.
  • 15 funds opened new Cabaletta Bio positions in Q2 2020 and 4 closed out, a net change of +11 holders.
  • The largest Cabaletta Bio buyer in Q2 2020 was BlackRock, an estimated $2.41M added.
  • The largest Cabaletta Bio seller in Q2 2020 was Deerfield Management, an estimated $6.28M sold.

Based on aggregated 13F filings for Q2 2020.